| Literature DB >> 19804638 |
Peter Schüffler1, Thomas Mikeska, Andreas Waha, Thomas Lengauer, Christoph Bock.
Abstract
DNA methylation is a key mechanism of epigenetic regulation that is frequently altered in diseases such as cancer. To confirm the biological or clinical relevance of such changes, gene-specific DNA methylation changes need to be validated in multiple samples. We have developed the MethMarker http://methmarker.mpi-inf.mpg.de/ software to help design robust and cost-efficient DNA methylation assays for six widely used methods. Furthermore, MethMarker implements a bioinformatic workflow for transforming disease-specific differentially methylated genomic regions into robust clinical biomarkers.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19804638 PMCID: PMC2784320 DOI: 10.1186/gb-2009-10-10-r105
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583